AstraZeneca to manufacture cancer killer in Singapore
AstraZeneca says it will invest $1.5 billion in building a manufacturing facility in Singapore for antibody-drug conjugates.
The biopharmaceutical giant announced on Monday.
AstraZeneca aimed to start designing and construction of the manufacturing facility by the end of this year, with targeted operational readiness from 2029.
According to the company, ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody.
(Xinhua/NAN)
We have recently deactivated our website's comment provider in favour of other channels of distribution and commentary. We encourage you to join the conversation on our stories via our Facebook, Twitter and other social media pages.
More from Peoples Gazette
Politics
Katsina youths pledge to deliver over 2 million votes to Atiku
“Katsina State is Atiku’s political base because it is his second home.”
Anti-Corruption
EFCC arrests 78 alleged internet fraudsters in Enugu, Imo
EFCC operatives have arrested 78 people for suspected internet fraud in Imo and Enugu.
Rights
Court declines terrorist negotiator Mamu’s request to be transferred from SSS custody to prison
Justice Inyang Ekwo, in a ruling, dismissed the application on the ground of insecurity of the custodial facility.
Economy
Nigeria witnessing structural economic changes under Tinubu, SLTV boss claims
“Sometimes we don’t see these impacts immediately, but they take some time to manifest,” said Mr Nwafor.
Education
Ten casualties recorded in Chinese primary school knife attack
The incident occurred in a primary school in Guixi around midday on Monday. Most of the pupils are between the ages of six and 12.
World
Lebanon declares three-day mourning for Iranian president, Hezbollah sends condolences
Mr Raisi was “a supporter and friend of the resistance movements and their standard-bearer in all political and diplomatic forums around the world.”
Economy
UK reports Air Peace to NCAA over safety regulations violations
The flight crew was unfamiliar with the approved company procedures and manuals, said the UK’s aviation body.
